XML 21 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Dialysis and related lab patient service revenues $ 2,718,403,000 $ 2,494,609,000 $ 5,309,477,000 $ 4,917,395,000
Provision for uncollectible accounts (49,406,000) (109,600,000) (23,861,000) (216,658,000)
Net dialysis and related lab patient service revenues 2,668,997,000 2,385,009,000 5,285,616,000 4,700,737,000
Other revenues 217,956,000 314,390,000 450,781,000 629,913,000
Total revenues 2,886,953,000 2,699,399,000 5,736,397,000 5,330,650,000
Operating expenses and charges:        
Patient care costs and other costs 2,069,089,000 1,894,664,000 4,104,674,000 3,746,709,000
General and administrative 264,094,000 262,796,000 530,623,000 525,691,000
Depreciation and amortization 147,079,000 140,026,000 289,878,000 272,910,000
Equity investment (income) loss (9,795,000) 825,000 (9,950,000) 148,000
Provision for uncollectible accounts (2,100,000) (606,000) (8,100,000) 1,304,000
Investment and other asset impairments 11,245,000 0 11,245,000 15,168,000
Goodwill impairment charges 3,106,000 10,498,000 3,106,000 34,696,000
Gain on changes in ownership interests, net (33,957,000) 0 (33,957,000) (6,273,000)
Gain on settlement, net 0 0 0 (526,827,000)
Total operating expenses and charges 2,448,761,000 2,308,203,000 4,887,519,000 4,063,526,000
Operating income 438,192,000 391,196,000 848,878,000 1,267,124,000
Debt expense (119,692,000) (107,934,000) (233,208,000) (212,331,000)
Other income, net 1,994,000 4,798,000 6,576,000 8,784,000
Income from continuing operations before income taxes 320,494,000 288,060,000 622,246,000 1,063,577,000
Income tax expense 83,868,000 101,915,000 154,605,000 383,580,000
Net income from continuing operations 236,626,000 186,145,000 467,641,000 679,997,000
Net income (loss) from discontinued operations, net of tax 69,696,000 (24,520,000) 63,910,000 (18,087,000)
Net income 306,322,000 161,625,000 531,551,000 661,910,000
Less: Net income attributable to noncontrolling interests (39,046,000) (34,624,000) (85,589,000) (87,212,000)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 39,046,000 34,624,000 85,589,000 87,210,000
Net income attributable to DaVita Inc. $ 267,276,000 $ 127,001,000 $ 445,962,000 $ 574,698,000
Earnings per share:        
Basic net income from continuing operations per share attributable to DaVita Inc. $ 1.16 $ 0.79 $ 2.23 $ 3.09
Basic net income per share attributable to DaVita Inc. 1.56 0.66 2.54 3.00
Diluted net income from continuing operations per share attributable to DaVita Inc. 1.15 0.78 2.19 3.04
Diluted net income per share attributable to DaVita Inc. $ 1.53 $ 0.65 $ 2.51 $ 2.95
Weighted average shares for earnings per share:        
Basic (in shares) 171,617,238 191,088,216 175,267,270 191,728,913
Diluted (in shares) 174,105,884 193,987,983 177,949,934 194,630,936
Net income from continuing operations $ 199,603,000 $ 151,292,000 $ 390,618,000 $ 592,197,000
Net income (loss) from discontinued operations 67,673,000 (24,291,000) 55,344,000 (17,499,000)
Net income attributable to DaVita Inc. $ 267,276,000 $ 127,001,000 $ 445,962,000 $ 574,698,000